Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Best and Worst Investments of 2012

By Ben Steverman - 2012-12-12T21:04:13Z

Photograph by Zimo

Company Symbol % Change
6 of 18

Best Equity Mutual Fund

Fidelity Select Biotechnology Portfolio

+37.5%

The Fidelity Select Biotechnology Portfolio (FBIOX) spreads $2.7 billion in assets over 157 biotechnology stocks. A top holding is Gilead Sciences Inc. (GILD), the California-based biopharmaceutical company that saw shares rise 83 percent in the first 11 months of 2012 on government approvals of HIV treatments.

Universe and criteria: 1,200 open-ended, U.S.-based equity mutual funds with assets of $500 million or more.

Advertisement